releases
‘DNA’ podcast Season 2 explores COVID, science and trust in communities
Aug. 23, 2021—Listen to Episode 1, Blueprint for a Pandemic-Ready Society, and subscribe on your favorite platform. The first episode of the second season of Vanderbilt University Medical Center’s original podcast series, Vanderbilt Health DNA: Discoveries in Action, tackles bold questions and issues pushed to the surface by COVID-19. This season, the award-winning 10-episode series delves into...
First Listen: Season 2 ‘Vanderbilt Health DNA’ podcast trailer
Aug. 16, 2021—New episodes of the #ListenDNA podcast series drop every week starting Aug. 23.
TRIAD,TEIS partnership expands early intervention services
Jul. 22, 2021—The Tennessee Department of Intellectual and Developmental Disabilities (DIDD) has renewed its contract with Vanderbilt Kennedy Center’s Treatment and Research Institute for Autism Spectrum Disorders (TRIAD) to continue and expand a partnership with Tennessee Early Intervention System (TEIS).
Pediatricians see spike in RSV cases, urge parents to be on lookout for symptoms
Jun. 23, 2021—“We are seeing a spike in respiratory illnesses, especially RSV (respiratory syncytial virus) and parainfluenza, which cause croup and bronchiolitis in young children and flu-like symptoms in older children and adults,” said James Antoon, MD, PhD, FAAP, assistant professor of Pediatrics at Children’s Hospital at Vanderbilt.
Two VUMC physician-scientists win Burroughs Wellcome Fund Career Awards
Jun. 21, 2021—Two physician-scientist Instructors in Medicine at Vanderbilt University Medical Center (VUMC) — Jeeyeon Cha, MD, PhD, and Celestine Wanjalla, MD, PhD — are among 12 recipients of the 2021 Burroughs Wellcome Fund (BWF) Career Award for Medical Scientists.
COVID-19 pandemic brought changes in cigarette smoking: study
Jun. 9, 2021—Smokers who believed they were at increased risk of getting COVID-19 during the pandemic, or having a more severe case, were more likely to quit while those whoperceived more stress increased smoking, according to new research published in the Journal of General Internal Medicine.
National Black Family Cancer Awareness Week is call to action
Jun. 9, 2021—National Black Family Cancer Awareness Week, June 17-23, aims to spur conversations followed by actions to make advancements in care more equitable.
VUMC team develops potential treatment for life-threatening microbial inflammation
Jun. 8, 2021—A cell-penetrating peptide developed by researchers at Vanderbilt University Medical Center can prevent, in an animal model, the often-fatal septic shock that can result from bacterial and viral infections.
Patient of Monroe Carell Jr. Children’s Hospital at Vanderbilt first in world to receive new investigational gene editing therapy
Jun. 3, 2021—A 9-year-old patient of Monroe Carell Jr. Children’s Hospital at Vanderbilt is the first in the world to receive an investigational gene editing therapy for Methylmalonic Acidemia (MMA), a rare genetic disorder diagnosed at birth.
VUMC’s DNA podcast garners award
May. 27, 2021—Vanderbilt University Medical Center’s original podcast series, Vanderbilt Health DNA: Discoveries in Action, was named Healthcare Podcast of the Year at the 2021 Healthcare and IT Marketing Community (HITMC) Awards.
Vanderbilt researchers present new data on clinical trials at ASCO 2021
May. 26, 2021—Vanderbilt-Ingram Cancer Center researchers will present data on clinical trials involving targeted therapies, immunotherapies and drug combination synergies at the 2021 American Society of Clinical Oncology Annual Meeting, June 4-8. The meeting is a virtual event this year.
Analysis reveals macrophages associated with kidney cancer recurrence
May. 24, 2021—A white blood cell, the TREM2/APOE/C1Q-positive macrophage, has been identified as a potential biomarker to predict recurrence of the most common type of kidney cancer and as a possible target for drug development.
